Literature DB >> 2567091

Blood donors with indeterminate anti-p24gag reactivity in HIV-1 western blot: absence of infectivity to transfused patients and in virus culture.

C L van der Poel1, P N Lelie, H W Reesink, P J van Exel-Oehlers, M Tersmette, R van den Akker, M Gonzalves, J G Huisman.   

Abstract

During a follow-up period of 23-40 months, 7 regular blood donors had persistently, and 4 had intermittently indeterminate anti-p24gag reactivity in human immunodeficiency virus (HIV)-1 Western Blot. Serological testing and viral cultures revealed that these donors had no signs of infection for HIV-1, HIV-2, human T-cell lymphotropic virus (HTLV)-4, and HTLV-1. Extensive interviewing and physical examination of these donors revealed neither risk factors, nor signs of HIV infection in the tested donors. Ten recipients, who were transfused with blood products from 6 of these 11 anti-p24gag-positive donors, were traced back. Six months after transfusion, no serological or clinical signs of HIV-1, HIV-2, or HTLV-1 infection were observed in these patients. It is concluded that blood donors with persistent or intermittent anti-p24gag reactivity in HIV-1 Western Blot, without development of antibodies to other HIV-encoded proteins in later blood samples, do not transmit the described retroviruses to transfused patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567091     DOI: 10.1111/j.1423-0410.1989.tb02020.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Evaluation of a line immunoassay for the differential detection of antibodies to human immunodeficiency virus.

Authors:  R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

Review 3.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

4.  Evaluation of the Genetic Systems Corp. Integra HIV-1 Pageblot system.

Authors:  C A Starkey; B Yen-Lieberman; M R Proffitt
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.

Authors:  R T Davey; L R Deyton; J A Metcalf; M Easter; J A Kovacs; M Vasudevachari; M Psallidopoulos; L M Thompson; J Falloon; M A Polis
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.